News

• 

   10.12.2025

  Tuberculosis: Scientists develop novel drug candidate for combating resistant pathogens

  Researchers at Martin Luther University Halle-Wittenberg (MLU) and the Research Center Borstel, Leibniz Lung Center have developed a promising new substance for targeting bacteria that cause tuberculosis. The team have produced a compound that inhibits the pathogens’ ability to produce energy and causes them to die. Established drugs work in a similar fashion, but the pathogen is becoming increasingly resistant to these medications. The study was conducted joi

• 

   08.12.2025

  Neues Weißbuch zeigt: Allergien stellen eine wachsende Herausforderung dar

  Die fünfte, umfassend überarbeitete und erweiterte Auflage des „Weißbuch Allergie in Deutschland“ ist im Oktober dieses Jahres im Springer Medizin Verlag erschienen. Ein zentraler inhaltlicher Beitrag dieses Standardwerks stammt auch in dieser Auflage von Prof. Uta Jappe vom Forschungszentrum Borstel, Leibniz Lungenzentrum (FZB). Gemeinsam mit den Kollegen Jörg Kleine-Tebbe✝, Berlin, und Richard Brans, Osnabrück, beleuchtet sie darin aktuelle wissenschaftliche Er

• 

   08.12.2025

  Antibiotic resistance can also make bacteria more vulnerable

  Antibiotic resistance is one of the greatest challenges in modern medicine. A new study now shows that the pathogen Haemophilus influenzae can develop a previously unknown and genetically highly unstable resistance mechanism. This so-called unstable heteroresistance is often not detected by standard resistance tests, which can in the worst case lead to treatment failures. The underlying cause is genomic alterations in the ompP2 gene, which can revert back to their origin